Inicio › Dermatomiositis › Illinois

Ensayos clínicos de Dermatomiositis en Illinois

3 estudios sobre Dermatomiositis buscan participantes en Illinois.

Texto oficial del estudio (inglés)

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Research Site, Willowbrook

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06455449

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago

ReclutandoFase 2/3

Edades de 6 a 75 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

The University of Chicago Medical Center, Chicago

ReclutandoFase 1

Edades de 18 a 74 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07085104

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.